QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 piper-sandler-maintains-overweight-on-praxis-precision-medicine-maintains-270-price-target

Piper Sandler analyst Yasmeen Rahimi maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Overweight and maintains $270 ...

 value-of-praxis-precision-medicines-lead-program-in-essential-tremor-alone-is-underappreciated-analyst

Needham rates Praxis Precision Medicines Buy with a $145 target. Key programs include ulixacaltamide for essential tremor (Phas...

 needham-initiates-coverage-on-praxis-precision-medicine-with-buy-rating-announces-price-target-of-145

Needham analyst Ami Fadia initiates coverage on Praxis Precision Medicine (NASDAQ:PRAX) with a Buy rating and announces Pric...

 guggenheim-initiates-coverage-on-praxis-precision-medicine-with-buy-rating-announces-price-target-of-155

Guggenheim analyst Yatin Suneja initiates coverage on Praxis Precision Medicine (NASDAQ:PRAX) with a Buy rating and announce...

 truist-securities-maintains-buy-on-praxis-precision-medicine-maintains-150-price-target

Truist Securities analyst Joon Lee maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and maintains $150 price tar...

 hc-wainwright--co-reiterates-buy-on-praxis-precision-medicine-maintains-105-price-target

HC Wainwright & Co. analyst Douglas Tsao reiterates Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and maintains $10...

 praxis-precision-medicines-advances-precision-therapies-for-cns-disorders-anticipates-key-milestones-in-seizure-and-pediatric-epilepsy-treatment

 Praxis Precision Medicines, Inc. (NASDAQ:PRAX), a clinical-stage biopharmaceutical company translating genetic insights into t...

 baird-initiates-coverage-on-praxis-precision-medicine-with-outperform-rating-announces-price-target-of-117

Baird analyst Joel Beatty initiates coverage on Praxis Precision Medicine (NASDAQ:PRAX) with a Outperform rating and announc...

 hc-wainwright--co-reiterates-buy-on-praxis-precision-medicine-maintains-105-price-target

HC Wainwright & Co. analyst Douglas Tsao reiterates Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and maintains $10...

 praxis-precision-medicines-priced-200m-offering-of-33m-shares-at-5650share

Praxis Precision Medicines, Inc. (NASDAQ:PRAX), a clinical-stage biopharmaceutical company translating genetic insights into th...

 why-westport-fuel-systems-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected ...

 jefferies-maintains-buy-on-praxis-precision-medicine-raises-price-target-to-128

Jefferies analyst Kambiz Yazdi maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and raises the price target from...